drugset / Trial / NCT02530398

A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites

NCT02530398

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the tolerance and safety of cinobufacini injection intraperitoneal treatment on digestive system cancer patients with malignant ascites, and propose dosage regimens for future clinical trials. The clinical trial is divided into two parts, including single and successive administration.

Timeline

Start
2015-07
Primary completion
2018-04
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cinobufacini Traditional medicine (herbal / TCM) 15 ml Other
Subject Cinobufacini Traditional medicine (herbal / TCM) 180 ml Other